Arkolith/Insider Trading/MNPR/Form 4

Radhakrishnan Karthik

Chief Financial OfficerMonopar Therapeutics (MNPR) · full profile →Form 4 · filed Oct 30, 2024
Net Buying
Open-Market Buys
$25K
Open-Market Sells
$0
Net Open-Market Flow
$25K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 28, 2024Buy(P)2K$16.25$25K2K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-24-032626) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML